ScholarIQanswers from OpenAlex & ORCID
Yi‐Hsiang Huang
ResearcherPublications, citations & collaboration network
Yi‐Hsiang Huang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yi‐Hsiang Huang have?
ScholarIQindexed works
Yi‐Hsiang Huang has 799 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yi‐Hsiang Huang have?
ScholarIQcitation count
Yi‐Hsiang Huang has 22,988 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yi‐Hsiang Huang?
ScholarIQh-index
Yi‐Hsiang Huang has an h-index of 63 in OpenAlex.
What is the i10-index of Yi‐Hsiang Huang?
ScholarIQi10-index
Yi‐Hsiang Huang has an i10-index of 383 in OpenAlex.
What is the ORCID of Yi‐Hsiang Huang?
ScholarIQorcid
The ORCID for Yi‐Hsiang Huang is on the source record.
What is the OpenAlex record for Yi‐Hsiang Huang?
ScholarIQopenalex
The OpenAlex for Yi‐Hsiang Huang is on the source record.
What are the most-cited papers on Yi‐Hsiang Huang?
ScholarIQmost cited works
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, Olivier Govaere, Matthias Pinter, Marta Szydlowska, Revant Gupta, Mengjie Qiu, Aleksandra Deczkowska, Assaf Weiner, Florian L. Müller, Ankit Sinha, Ekaterina Friebel, Thomas Engleitner, Daniela Lenggenhager, Anja Moncsek, Danijela Heide, Kristin Stirm, Jan Kosla, Eleni Kotsiliti, Valentina Leone, Michael Dudek, Suhail Yousuf, Donato Inverso, Indrabahadur Singh, Ana Teijeiro, Florian Castet, Carla Montironi, Philipp K. Haber, Dina Tiniakos, Pierre Bédossa, Simon Cockell, Ramy Younes, Michèle Vacca, Fabio Marra, Jörn M. Schattenberg, Michael Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D’Alessio, Nicola Personeni, Lorenza Rimassa, Ann K. Daly, Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein, Arndt Vogel, Markus Peck‐Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan‐Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G. Augustin, Adrian T. Billeter, Beat P. Müller‐Stich, Hiroto Kikuchi, Dan G. Duda, Fabian Kütting, Dirk‐Thomas Waldschmidt, Matthias Ebert, Nuh N. Rahbari, Henrik E. Mei, Axel Schulz, Marc Ringelhan, Nisar P. Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean‐François Dufour, Thomas U. Marron, Ahmed O. Kaseb, Masatoshi Kudo, Yi‐Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N. Marche, Thomas Decaens, David J. Pinato, Roland Rad, Joachim C. Mertens, Achim Weber, Kristian Unger
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
L.-T. Chen, Erika Martinelli, Ann‐Lii Cheng, George Pentheroudakis, Si-bei Qin, G.S. Bhattacharyya, Masafumi Ikeda, Ho Yeong Lim, Gwo Fuang Ho, Su Pin Choo, Zhenggang Ren, Hemant Malhotra, Makoto Ueno, Baek‐Yeol Ryoo, Tina Kiang, David Tai, Arndt Vogel, Andrés Cervantes, Sheng‐Nan Lu, Chung‐Jen Yen, Yi‐Hsiang Huang, San‐Chi Chen, Chiun Hsu, Ying‐Chun Shen, Josep Tabernero, Yun Yen, Chih‐Hung Hsu, Takayuki Yoshino, J.-Y. Douillard
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen, Yi‐Hsiang Huang, Wan‐Long Chuang, Chun‐Che Lin, Chia‐Chi Wang, Wei‐Wen Su, Ming‐Yao Chen, Cheng‐Yuan Peng, Rong‐Nan Chien, Yi‐Wen Huang, Horng‐Yuan Wang, Chih‐Lin Lin, Sheng‐Shun Yang, Tsung‐Ming Chen, Lein‐Ray Mo, Shih‐Jer Hsu, Kuo‐Chih Tseng, Tsai‐Yuan Hsieh, Fat‐Moon Suk, Chi‐Tan Hu, Ming‐Jong Bair, Cheng‐Chao Liang, Yung‐Chao Lei, Tai‐Chung Tseng, Chi‐Ling Chen, Jia‐Horng Kao